Active Ingredient: TEDUGLUTIDE RECOMBINANT
Proprietary Name: GATTEX KIT
Dosage Form; Route of Administration: POWDER; SUBCUTANEOUS
Strength: 5MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N203441
Product Number: 001
Approval Date: Dec 21, 2012
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
